To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
NCT00323817 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 282
Last updated 2015-05-28
Summary
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
Conditions
- Functional Dyspepsia
Interventions
- DRUG
-
Z-338
Sponsors & Collaborators
-
Zeria Pharmaceutical
lead INDUSTRY
Principal Investigators
-
Jan Tack, PhD, MD · Universitaire Ziekenhuizen KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-04-30
- Completion
- 2009-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
Clinical Trial of DA-5212 in Patients with Functional Dyspepsia
NCT05842408 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain
NCT01637571 ·Status: WITHDRAWN ·Phase: PHASE4
-
DLBS2411 Treatment For Functional Dyspepsia
NCT05248802 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04703374 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
NCT06664008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Buspirone for Weak or Absent Esophageal Peristalsis
NCT05629325 ·Status: RECRUITING ·Phase: PHASE4
-
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
NCT00232037 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects
NCT03558425 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
NCT00232024 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers
NCT04352686 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
NCT05108038 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.
NCT02831543 ·Status: UNKNOWN ·Phase: PHASE3
-
14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations
NCT00813306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
NCT01005251 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
NCT00171457 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Domperidone for Treatment of Upper Gastrointestinal Disorders
NCT03128398 ·Status: NO_LONGER_AVAILABLE
-
An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
NCT01370863 ·Status: TERMINATED ·Phase: PHASE2
-
YM443 in Subjects With Functional Dyspepsia
NCT00102310 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects
NCT01154634 ·Status: COMPLETED ·Phase: PHASE2